DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF MEETING 1 
June 1-2, 1992 
The Recombinant DNA Advisory Committee (RAC) was convened for its forty-ninth 
meeting at 9:00 a.m. on June 1, 1992, in Building 3 1C, Conference Room 6, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892. Dr. Barbara E. 
Murray (Chair) presided. In accordance with Public Law 92-463, the meeting was open 
to the public. TTie following were present for all or part of the meeting: 
Committee members: 
John H. Barton, Stanford Law School 
A1 W. Bourquin, Ecova Italia 
Constance E. Brinckerhoff, Dartmouth Medical School 
Alexander M. Capron, University of Southern California 
Ira H. Carmen, University of Illinois 
Patricia A. DeLeon, University of Delaware 
Roy H. Doi, University of California 
Krishna R. Dronamraju, The Genetics Foundation 
E. Peter Geiduschek, University of California, San Diego 
Robert Haselkom, University of Chicago 
Susan S. Hirano, University of Wisconsin 
William N. Kelley, University of Pennsylvania Medical Center 
Donald J. Krogstad, Tulane University School of Medicine 
Brigid G. Leventhal, Johns Hopkins Hospital 
A. Dusty Miller, Fred Hutchinson Cancer Research Center 
Barbara E. Murray, University of Texas 
Robertson Parkman, Childrens Hospital of Los Angeles 
Leonard E. Post, Parke-Davis Pharmaceutical Division 
Moselio Schaechter, Tufts University School of Medicine 
Marian G. Secundy, Howard University College of Medicine 
LeRoy B. Walters, Georgetown University 
^The RAC is advisory to the National Institutes of Health (NIH), and its 
recommendations should not be considered as final or accepted. The Office of 
Recombinant DNA Activities should be consulted for NIH policy on specific 
issues. 
Recombinant DNA Research, Volume 15 
[667] 
